Matthias Schefzyk

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases.

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases.

Journal: Frontiers in medicine

Published: May 28, 2025

Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors.

Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors.

Journal: Cancers

Published: May 16, 2025

Toll-Like Receptor 8 is Expressed in Monocytes in Contrast to Plasmacytoid Dendritic Cells and Mediates Aberrant Interleukin-10 Responses in Patients With Systemic Sclerosis.

Toll-Like Receptor 8 is Expressed in Monocytes in Contrast to Plasmacytoid Dendritic Cells and Mediates Aberrant Interleukin-10 Responses in Patients With Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 29, 2024

Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders.

Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders.

Journal: Autoimmunity reviews

Published: April 19, 2024

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid.

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 08, 2023

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.

Journal: Autoimmunity reviews

Published: February 15, 2023

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 18, 2023

Kutane thrombotische Mikroangiopathie bei gemischter Kryoglobulinämie bei einer jungen Frau.

Kutane thrombotische Mikroangiopathie bei gemischter Kryoglobulinämie bei einer jungen Frau.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: June 17, 2022

Cutaneous thrombotic microangiopathy due to mixed cryoglobulinemia in a young woman.

Cutaneous thrombotic microangiopathy due to mixed cryoglobulinemia in a young woman.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: April 29, 2022

Hemorrhagic rash on the legs.

Hemorrhagic rash on the legs.

Journal: JAAD case reports

Published: May 27, 2021

Congenital deficiency reveals critical role of ISG15 in skin homeostasis.

Congenital deficiency reveals critical role of ISG15 in skin homeostasis.

Journal: The Journal of clinical investigation

Published: July 16, 2020

Simultaneous Cutaneous and Laryngeal Cryptococcosis

Simultaneous Cutaneous and Laryngeal Cryptococcosis

Journal: Pneumologie (Stuttgart, Germany)

Published: May 15, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026